• IBM Ventureshas announced new investments inSQKandQodeX Quantum, two early-stage startups participating in theAlchemist Chicagodeep tech accelerator. • These investments represent a strategic move by IBM to bolster the quantum software ecosystem by supporting founders who are transitioning theoretical breakthroughs into industrial applications. • Both startups were selected from theDualityaccelerator program to advance into the second phase of Alchemist Chicago, a business acceleration stage that provides venture capital and intensive mentorship for enterprise scaling. • SQK, based in Seattle, is developing hybrid quantum-classical algorithms specifically for medical image reconstruction. • The company’s technology aims to improve the diagnostic accuracy and speed of imaging in fields like oncology, cardiovascular health, and neuroscience-addressing a critical computational bottleneck in modern healthcare. • Meanwhile, QodeX Quantum, a Chicago-native startup, is focused on enabling quantum-native AI models.
Article Summaries:
- IBM Ventures has invested in two early‑stage quantum‑software startups, SQK and QodeX Quantum, both part of the Alchemist Chicago deep‑tech accelerator. The funding is aimed at accelerating the transition of theoretical quantum breakthroughs into industrial applications. SQK, based in Seattle, is developing hybrid quantum‑classical algorithms for medical image reconstruction to improve diagnostic speed and accuracy. QodeX Quantum, a Chicago‑based company, focuses on quantum‑native AI models that integrate quantum processing into machine‑learning workflows for enterprise analytics. The investments align with IBM’s Illinois strategy, which includes deploying the IBM Quantum System Two at the Illinois Quantum and Microelectronics Park and establishing a National Quantum Algorithm Center.
Sources: